// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship Format (SDRF)-Proteomics. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is: HUPO-PSI SDRF.\n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often prevents dat",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "PP CELL biological replicate ENVO HTML PO HANCESTRO AC disease cell type label EFO CLO DOID DISCLAIMS REQUIRED REQUIRES CL URI NCIT:C25683 ANY PRIDE:0000832 organism COLUMN OF FDR LC TMT proteomics data acquisition method MHC PRIDE:0000831 WILL MIAME INCLUDING MUST RAW USE PRIDE:0000590 PRIDE:0000833 RFC INITIATIVE MOD DDA PRIDE:0000659 PURPOSE organism part IDF UBERON NCIT pooled sample IMPORTANT NCI DJ III BUT PEPTIDESEQ TO INFORMATION SHOULD IS SILAC EBI TA PS spiked compound PRIDE XML MS:1001251 EM individual JA data file CN THE ancestry category ... PATO:0000461 RECOMMEND PMCID HEREIN fraction identifier SAMN TAB technical replicate instrument EXPRESS PTM ISA DIA ROW VK age MINOR SN disease stage developmental stage MAY README PRM NCIT:C25714 MC BTO MS:1000484 WARRANTY HUPO ALL exclamation MS characteristics AND COULD HF source name SWATH ID RIGHTS II CV PRIDE:0000834 NOT FAIR HCD QY LIMITED MIAPE STANDARDS MERCHANTABILITY biosample accession number CF mass IMPLIED OPTIONAL SAMEA WARRANTIES THAT PMID HLA MT OR sex BMC MAJOR EW FOR SRM RECOMMENDED YAML MONDO not TIP CS ZFA SP NT VCF sample PSI NOTE SDRF INFRINGE PROTEOMICS PARTICULAR CT URL PATCH PATO BE FITNESS NCBI MAGE LI file your BRENDA CPTAC cleavage agent details AS SHALL"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship Format (SDRF)-Proteomics. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is: HUPO-PSI SDRF.\n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often prevents dat",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "PP CELL biological replicate ENVO HTML PO HANCESTRO AC disease cell type label EFO CLO DOID DISCLAIMS REQUIRED REQUIRES CL URI NCIT:C25683 ANY PRIDE:0000832 organism COLUMN OF FDR LC TMT proteomics data acquisition method MHC PRIDE:0000831 WILL MIAME INCLUDING MUST RAW USE PRIDE:0000590 PRIDE:0000833 RFC INITIATIVE MOD DDA PRIDE:0000659 PURPOSE organism part IDF UBERON NCIT pooled sample NCI DJ III BUT PEPTIDESEQ TO INFORMATION SHOULD IS SILAC EBI TA PS spiked compound PRIDE MS:1001251 EM individual JA data file CN THE ... PATO:0000461 RECOMMEND PMCID HEREIN fraction identifier SAMN TAB technical replicate instrument EXPRESS PTM ISA DIA ROW VK age MINOR SN disease stage MAY README PRM NCIT:C25714 MC BTO MS:1000484 WARRANTY HUPO ALL MS AND COULD HF SWATH RIGHTS II CV PRIDE:0000834 NOT FAIR HCD QY LIMITED MIAPE STANDARDS MERCHANTABILITY biosample accession number CF mass IMPLIED OPTIONAL SAMEA WARRANTIES THAT PMID HLA MT OR sex BMC MAJOR EW FOR SRM RECOMMENDED YAML MONDO CS ZFA SP NT VCF PSI SDRF INFRINGE PROTEOMICS PARTICULAR CT URL PATCH PATO BE FITNESS NCBI MAGE LI BRENDA CPTAC cleavage agent details AS SHALL"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\nrattus norvegicus |NCBITaxon:10116 |Rat\ndanio rerio |NCBITaxon:7955 |Zebrafish\ndrosophila melanogaster |NCBITaxon:7227 |Fruit fly\narabidopsis thaliana |NCBITaxon:3702 |Thale cress\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nblood plasma |UBERON:0001969 |Blood plasma\nliver |UBERON:0002107 |Liver tissue\nbrain |UBERON:0000955 |Brain\nheart |UBERON:0000948 |Heart\nkidney |UBERON:0002113 |Kidney\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hou",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "age UBERON:0002113 MONDO:0100096 PATO:0001421 organism part developmental stage xenograft PO APP disease UBERON MAY cell type EFO MONDO:0004989 DOID COVID UBERON:0002107 CL:0000066 CL:0000624 UBERON:0001969 CL:0000057 synthetic peptide UBERON:0000948 MONDO CL UBERON:0000178 exclamation organism enrichment process NOTE SDRF ID CL:0000236 depletion PATO:0000461 PATO UBERON:0000955 CL:0000235 CL:0000084 NCBI MUST MONDO:0004975 PDX PTM MONDO:0005148 CL:0000815"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\nrattus norvegicus |NCBITaxon:10116 |Rat\ndanio rerio |NCBITaxon:7955 |Zebrafish\ndrosophila melanogaster |NCBITaxon:7227 |Fruit fly\narabidopsis thaliana |NCBITaxon:3702 |Thale cress\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nblood plasma |UBERON:0001969 |Blood plasma\nliver |UBERON:0002107 |Liver tissue\nbrain |UBERON:0000955 |Brain\nheart |UBERON:0000948 |Heart\nkidney |UBERON:0002113 |Kidney\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hou",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "age UBERON:0002113 MONDO:0100096 PATO:0001421 organism part developmental stage xenograft PO APP disease UBERON MAY cell type EFO MONDO:0004989 DOID COVID UBERON:0002107 CL:0000066 CL:0000624 UBERON:0001969 CL:0000057 synthetic peptide UBERON:0000948 MONDO CL UBERON:0000178 organism enrichment process SDRF ID CL:0000236 depletion PATO:0000461 PATO UBERON:0000955 CL:0000235 CL:0000084 NCBI MUST MONDO:0004975 PDX PTM MONDO:0005148 CL:0000815"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "disease stage Ann Arbor stage organism part HANCESTRO NCIT:C65108 pre-existing condition NCIT:C15632 NCIT NCI IMPORTANT Dukes stage treatment status menopausal status NCIT:C28078 NCIT:C4870 NCIT:C18206 treatment response ER CHEBI:27899 NCIT:C27966 HIPAA MONDO tumor grade smoking status compound exclamation weight GDPR MONDO:0005044 TNM staging NCIT:C65106 dose NCIT:C15262 PR NCIT:C65107 SDRF individual TNM ID treatment body mass index HANCESTRO:0009 IV ancestry category NCIT:C53554 sampling time point NCIT:C71732 NCIT:C27971 HANCESTRO:0005 AJCC CHEBI:28748 breast cancer subtype MONDO:0005148 NCIT:C28076"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "disease stage Ann Arbor stage organism part HANCESTRO NCIT:C65108 pre-existing condition NCIT:C15632 NCIT NCI Dukes stage treatment status menopausal status NCIT:C28078 NCIT:C4870 NCIT:C18206 treatment response ER CHEBI:27899 NCIT:C27966 HIPAA MONDO tumor grade smoking status compound weight GDPR MONDO:0005044 TNM staging NCIT:C65106 dose NCIT:C15262 PR NCIT:C65107 SDRF individual TNM ID treatment body mass index HANCESTRO:0009 IV ancestry category NCIT:C53554 sampling time point NCIT:C71732 NCIT:C27971 HANCESTRO:0005 AJCC CHEBI:28748 breast cancer subtype MONDO:0005148 NCIT:C28076"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nCV Term Format\n\nFor data file metadata columns that reference ontology terms, use the structured CV term format:\n\nNT={term name};AC={accession}\n\nExamples:\n\n- Dissociation method: NT=HCD;AC=PRIDE:0000590\n- Fractionation method: NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564\n- Instrument: NT=Q Exactive HF;AC=MS:1002523\n- Label: NT=TMT126;AC=PRIDE:0000285\n\nWhy use the structured format?\n\n1. Automated annotation: Many data file properties (instrument, acquisition method, dissociation method) can be automatically determined by software from raw files.\n2. Validation: Accession numbers enable automated validation against ontologies.\n3. Interoperability: Structured terms are unambiguous across different tools and databases.\n\n Unlike sample metadata (characteristics) which are typically annotated manually using simple term names, data file metadata benefits from the structured CV term format because these values are often extracted programmatically from instrument files.\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Mass Analyzer\n\nColumn: comment[MS2 mass analyzer]\n\nOntology: PSI-MS - Mass analyzer type (MS:1000443)\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nCommon values:\n\nAnalyzer |Accession\n\norbitrap |MS:100",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "PP AC label fragment mass tolerance UNIMOD:1 MS:1001045 REQUIRED PRIDE:0000561 PAGE MS:1000422 scan window lower limit MS:1000443 MS:1001313 MS:1000133 TMT ETD reduction reagent SH MS:1000081 PRIDE:0000590 MS:1000084 MOD fractionation method dissociation method SILAC collision energy TA PRIDE UNIMOD MS:1001251 UVPD MS:1001303 PRIDE:0000285 MS2 mass analyzer depletion fraction identifier alkylation reagent PRIDE:0000565 UNIMOD:35 DIA NCE SDS IAM DTT README MS:1000484 CID TOF precursor mass tolerance exclamation MS UNIMOD:4 HF MS:1002631 CV scan window upper limit HCD MS:1000264 PRIDE:0000553 MS:1000598 UNIMOD:21 MT MS1 scan range PRIDE:0000564 MS:1003246 SCX MS:1001306 RECOMMENDED MS:1001917 MS:1002523 TCEP IAA TIP CAA NT PSI NOTE SDRF OLS PRIDE:0000551 modification parameters cleavage agent details MS:1001309"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nCV Term Format\n\nFor data file metadata columns that reference ontology terms, use the structured CV term format:\n\nNT={term name};AC={accession}\n\nExamples:\n\n- Dissociation method: NT=HCD;AC=PRIDE:0000590\n- Fractionation method: NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564\n- Instrument: NT=Q Exactive HF;AC=MS:1002523\n- Label: NT=TMT126;AC=PRIDE:0000285\n\nWhy use the structured format?\n\n1. Automated annotation: Many data file properties (instrument, acquisition method, dissociation method) can be automatically determined by software from raw files.\n2. Validation: Accession numbers enable automated validation against ontologies.\n3. Interoperability: Structured terms are unambiguous across different tools and databases.\n\n Unlike sample metadata (characteristics) which are typically annotated manually using simple term names, data file metadata benefits from the structured CV term format because these values are often extracted programmatically from instrument files.\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Mass Analyzer\n\nColumn: comment[MS2 mass analyzer]\n\nOntology: PSI-MS - Mass analyzer type (MS:1000443)\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nCommon values:\n\nAnalyzer |Accession\n\norbitrap |MS:100",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "PP AC label fragment mass tolerance UNIMOD:1 MS:1001045 REQUIRED PRIDE:0000561 PAGE MS:1000422 scan window lower limit MS:1000443 MS:1001313 MS:1000133 TMT ETD reduction reagent SH MS:1000081 PRIDE:0000590 MS:1000084 MOD fractionation method dissociation method SILAC collision energy TA PRIDE UNIMOD MS:1001251 UVPD MS:1001303 PRIDE:0000285 MS2 mass analyzer depletion fraction identifier alkylation reagent PRIDE:0000565 UNIMOD:35 DIA NCE SDS IAM DTT MS:1000484 CID TOF precursor mass tolerance MS UNIMOD:4 HF MS:1002631 CV scan window upper limit HCD MS:1000264 PRIDE:0000553 MS:1000598 UNIMOD:21 MT MS1 scan range PRIDE:0000564 MS:1003246 SCX MS:1001306 RECOMMENDED MS:1001917 MS:1002523 TCEP IAA CAA NT PSI SDRF OLS PRIDE:0000551 modification parameters cleavage agent details MS:1001309"
  }
];
